
Willie J. Daniel Jr.
Examiner (ID: 12204, Phone: (571)272-7907 , Office: P/2462 )
| Most Active Art Unit | 2462 |
| Art Unit(s) | 2462, 2465, 2641, 2617, 2686 |
| Total Applications | 889 |
| Issued Applications | 433 |
| Pending Applications | 99 |
| Abandoned Applications | 374 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18164922
[patent_doc_number] => 20230031519
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-02
[patent_title] => COMPOSITION COMPRISING MELATONIN OR ITS DERIVATIVES WITH COENZYME Q10 AND USE THEREOF AGAINST AGEING OF THE SKIN
[patent_app_type] => utility
[patent_app_number] => 17/936733
[patent_app_country] => US
[patent_app_date] => 2022-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6259
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17936733
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/936733 | COMPOSITION COMPRISING MELATONIN OR ITS DERIVATIVES WITH COENZYME Q10 AND USE THEREOF AGAINST AGEING OF THE SKIN | Sep 28, 2022 | Abandoned |
Array
(
[id] => 19032301
[patent_doc_number] => 20240082116
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-14
[patent_title] => Self-Warming Hygienic Tissue
[patent_app_type] => utility
[patent_app_number] => 17/943998
[patent_app_country] => US
[patent_app_date] => 2022-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5672
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17943998
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/943998 | Self-Warming Hygienic Tissue | Sep 12, 2022 | Abandoned |
Array
(
[id] => 18252667
[patent_doc_number] => 20230079706
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-16
[patent_title] => Solid Cleansing Compositions and Methods for the Same
[patent_app_type] => utility
[patent_app_number] => 17/943103
[patent_app_country] => US
[patent_app_date] => 2022-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12244
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17943103
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/943103 | Solid Cleansing Compositions and Methods for the Same | Sep 11, 2022 | Pending |
Array
(
[id] => 19049430
[patent_doc_number] => 20240091399
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-21
[patent_title] => MEDICAL GRADE NANOFIBRILLAR CELLULOSE HYDROGEL, A METHOD FOR TREATING A SUBJECT IN NEED OF TREATMENT OF BODY WITH IMPLANTABLE MATERIAL AND A METHOD FOR MANUFACTURING THE MEDICAL GRADE NANOFIBRILLAR CELLULOSE HYDROGEL
[patent_app_type] => utility
[patent_app_number] => 17/941093
[patent_app_country] => US
[patent_app_date] => 2022-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13844
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17941093
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/941093 | MEDICAL GRADE NANOFIBRILLAR CELLULOSE HYDROGEL, A METHOD FOR TREATING A SUBJECT IN NEED OF TREATMENT OF BODY WITH IMPLANTABLE MATERIAL AND A METHOD FOR MANUFACTURING THE MEDICAL GRADE NANOFIBRILLAR CELLULOSE HYDROGEL | Sep 8, 2022 | Abandoned |
Array
(
[id] => 18281837
[patent_doc_number] => 20230097309
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => SOLID DISPERSIONS OF A ERB2 (HER2) INHIBITOR
[patent_app_type] => utility
[patent_app_number] => 17/895951
[patent_app_country] => US
[patent_app_date] => 2022-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9486
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17895951
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/895951 | SOLID DISPERSIONS OF A ERB2 (HER2) INHIBITOR | Aug 24, 2022 | Abandoned |
Array
(
[id] => 18139306
[patent_doc_number] => 20230013142
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-19
[patent_title] => IODINE COMPOUNDS FOR TREATING RESPIRATORY PATHOGENS
[patent_app_type] => utility
[patent_app_number] => 17/821895
[patent_app_country] => US
[patent_app_date] => 2022-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10912
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17821895
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/821895 | IODINE COMPOUNDS FOR TREATING RESPIRATORY PATHOGENS | Aug 23, 2022 | Pending |
Array
(
[id] => 18056241
[patent_doc_number] => 20220387327
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-08
[patent_title] => METHOD OF MANUFACTURING PHARMACEUTICAL COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/820781
[patent_app_country] => US
[patent_app_date] => 2022-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17345
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17820781
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/820781 | METHOD OF MANUFACTURING PHARMACEUTICAL COMPOSITIONS | Aug 17, 2022 | Abandoned |
Array
(
[id] => 18034573
[patent_doc_number] => 20220378788
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-01
[patent_title] => ORALLY DISINTEGRATING TABLET COMPRISING AMORPHOUS SOLID DISPERSION OF NILOTINIB AND IN VITRO CHARACTERIZATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/881390
[patent_app_country] => US
[patent_app_date] => 2022-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 52736
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 161
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17881390
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/881390 | ORALLY DISINTEGRATING TABLET COMPRISING AMORPHOUS SOLID DISPERSION OF NILOTINIB AND IN VITRO CHARACTERIZATION THEREOF | Aug 3, 2022 | Abandoned |
Array
(
[id] => 18018949
[patent_doc_number] => 20220370448
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => PHARMACEUTICAL COMPOSITION COMPRISING THIRD GENERATION SMALL MOLECULE EGFR INHIBITOR AND PREPARATION METHOD THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/875811
[patent_app_country] => US
[patent_app_date] => 2022-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6446
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17875811
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/875811 | PHARMACEUTICAL COMPOSITION COMPRISING THIRD GENERATION SMALL MOLECULE EGFR INHIBITOR AND PREPARATION METHOD THEREOF | Jul 27, 2022 | Pending |
Array
(
[id] => 18169331
[patent_doc_number] => 20230035942
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-02
[patent_title] => DELIVERY OF BIOLOGICS VIA MINERAL CRYSTALS FOR REGENERATIVE MEDICINE APPLICATIONS
[patent_app_type] => utility
[patent_app_number] => 17/814128
[patent_app_country] => US
[patent_app_date] => 2022-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6130
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17814128
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/814128 | DELIVERY OF BIOLOGICS VIA MINERAL CRYSTALS FOR REGENERATIVE MEDICINE APPLICATIONS | Jul 20, 2022 | Abandoned |
Array
(
[id] => 19262766
[patent_doc_number] => 20240206461
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-27
[patent_title] => DELIVERY PARTICLES WITH HIGH CORE:WALL RATIOS
[patent_app_type] => utility
[patent_app_number] => 18/554018
[patent_app_country] => US
[patent_app_date] => 2022-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23106
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18554018
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/554018 | DELIVERY PARTICLES WITH HIGH CORE:WALL RATIOS | Jul 12, 2022 | Pending |
Array
(
[id] => 19675979
[patent_doc_number] => 12187829
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-01-07
[patent_title] => Environmentally biodegradable microcapsules
[patent_app_type] => utility
[patent_app_number] => 17/861204
[patent_app_country] => US
[patent_app_date] => 2022-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 19576
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 218
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17861204
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/861204 | Environmentally biodegradable microcapsules | Jul 8, 2022 | Issued |
Array
(
[id] => 19960384
[patent_doc_number] => 12329856
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-06-17
[patent_title] => Crosslinked hyaluronic acid composition with local anesthetics
[patent_app_type] => utility
[patent_app_number] => 18/575483
[patent_app_country] => US
[patent_app_date] => 2022-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16960
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 865
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18575483
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/575483 | Crosslinked hyaluronic acid composition with local anesthetics | Jun 29, 2022 | Issued |
Array
(
[id] => 17944289
[patent_doc_number] => 20220331306
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-20
[patent_title] => Nicotine Pouch
[patent_app_type] => utility
[patent_app_number] => 17/853545
[patent_app_country] => US
[patent_app_date] => 2022-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8143
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17853545
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/853545 | Nicotine Pouch | Jun 28, 2022 | Pending |
Array
(
[id] => 19401406
[patent_doc_number] => 20240284917
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-29
[patent_title] => DELIVERY SYSTEMS
[patent_app_type] => utility
[patent_app_number] => 18/290538
[patent_app_country] => US
[patent_app_date] => 2022-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9104
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18290538
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/290538 | DELIVERY SYSTEMS | Jun 27, 2022 | Pending |
Array
(
[id] => 19343441
[patent_doc_number] => 20240252404
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-01
[patent_title] => POLYAMIDE-BASED MICROCAPSULES
[patent_app_type] => utility
[patent_app_number] => 18/290476
[patent_app_country] => US
[patent_app_date] => 2022-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18062
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18290476
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/290476 | POLYAMIDE-BASED MICROCAPSULES | Jun 20, 2022 | Pending |
Array
(
[id] => 18256583
[patent_doc_number] => 20230083622
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-16
[patent_title] => ORAL NOURISHING COMPOSITION AND METHODS THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/838344
[patent_app_country] => US
[patent_app_date] => 2022-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19313
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17838344
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/838344 | ORAL NOURISHING COMPOSITION AND METHODS THEREOF | Jun 12, 2022 | Pending |
Array
(
[id] => 17880384
[patent_doc_number] => 20220295861
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-22
[patent_title] => ORAL COMPOSITION WITH NANOCRYSTALLINE CELLULOSE
[patent_app_type] => utility
[patent_app_number] => 17/835000
[patent_app_country] => US
[patent_app_date] => 2022-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17802
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17835000
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/835000 | ORAL COMPOSITION WITH NANOCRYSTALLINE CELLULOSE | Jun 7, 2022 | Pending |
Array
(
[id] => 19387741
[patent_doc_number] => 20240277611
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-22
[patent_title] => SOL-GEL COMPOSITIONS FOR VETERINARY USE
[patent_app_type] => utility
[patent_app_number] => 18/566854
[patent_app_country] => US
[patent_app_date] => 2022-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8327
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18566854
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/566854 | SOL-GEL COMPOSITIONS FOR VETERINARY USE | May 31, 2022 | Pending |
Array
(
[id] => 19578741
[patent_doc_number] => 12144823
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-11-19
[patent_title] => Porous silicate and/or aluminosilicate matrix/cerium oxide nanoparticle nanocarrier for combination anti-cancer therapeutic and antioxidant delivery
[patent_app_type] => utility
[patent_app_number] => 17/731905
[patent_app_country] => US
[patent_app_date] => 2022-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 52
[patent_no_of_words] => 16376
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 145
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17731905
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/731905 | Porous silicate and/or aluminosilicate matrix/cerium oxide nanoparticle nanocarrier for combination anti-cancer therapeutic and antioxidant delivery | Apr 27, 2022 | Issued |